CORMEDIX INC. Cash and Restricted Cash
CORMEDIX INC. (CRMD) had Cash and Restricted Cash of $257.68 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $257.68M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $179.07M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $145.82M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $49.48M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $257.68M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $179.07M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $145.82M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $49.48M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $159.41M 10-Q · filed 2026-08-13 | $159.41M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $66.39M 10-Q · filed 2026-05-14 | $66.39M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $40.76M 10-Q · filed 2026-08-13 | $40.76M 10-K · filed 2025-03-25 |
| 2024-09-30 | $35.39M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $28.65M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $35.36M 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $43.82M 10-K · filed 2026-03-05 | $43.82M 10-K · filed 2024-03-12 |
| 2023-09-30 | $53.50M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $19.89M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $25.50M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $43.37M 10-K · filed 2025-03-25 | |
| 2022-09-30 | $43.47M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $49.15M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $45.62M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $53.55M 10-K · filed 2024-03-12 | |
| 2021-09-30 | $66.55M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $73.33M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $76.45M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $42.10M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $34.55M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $16.67M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $12.38M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $16.53M 10-K · filed 2022-03-29 | |
| 2019-09-30 | $20.32M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $14.73M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $18.43M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $17.80M 10-K · filed 2021-03-30 | |
| 2018-09-30 | $6.62M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $4.87M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $8.33M 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $10.55M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $5.38M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $8.11M 10-Q · filed 2018-08-14 | |
| 2017-03-31 | $6.99M 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $8.24M 10-K · filed 2019-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |